Home > News > Biophan Expands Biotechnology IP Portfolio to 114 Patents
March 29th, 2005
Biophan Expands Biotechnology IP Portfolio to 114 Patents
Abstract:
Biophan Technologies, Inc., a developer of next-generation biomedical technology, has announced continued growth of its intellectual property portfolio, reaching a total of 114 issued or filed patents in a range of cutting-edge biomedical fields. The newly-issued patents and recent patent applications claim important additional intellectual property coverage for the Company as it continues its development of advanced solutions for Magnetic Resonance Imaging (MRI) safety and image compatibility for surgical instruments and implanted devices, and other markets.
Source:
businesswire
Bookmark:
Announcements
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
Bacterial spare parts filter antibiotic residue from groundwater May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Patents/IP/Tech Transfer/Licensing
Innovation could bring flexible solar cells, transistors, displays May 22nd, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013